TRCN0000231737 Citations (1)
Originally described in: Integrated genetic and pharmacologic interrogation of rare cancers.Hong AL, Tseng YY, Cowley GS, Jonas O, Cheah JH, Kynnap BD, Doshi MB, Oh C, Meyer SC, Church AJ, Gill S, Bielski CM, Keskula P, Imamovic A, Howell S, Kryukov GV, Clemons PA, Tsherniak A, Vazquez F, Crompton BD, Shamji AF, Rodriguez-Galindo C, Janeway KA, Roberts CW, Stegmaier K, van Hummelen P, Cima MJ, Langer RS, Garraway LA, Schreiber SL, Root DE, Hahn WC, Boehm JS Nat Commun. 2016 Jun 22;7:11987. doi: 10.1038/ncomms11987. PubMed Journal
Articles Citing TRCN0000231737
| Articles |
|---|
| Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease. Chen H, Nisar MA, Mulla J, Li X, Cao K, Lu S, Nagaoka K, Wu S, Ting PS, Tseng TS, Lin HY, Yin XM, Feng W, Wu Z, Cheng Z, Mueller W, Bay A, Schechner L, Bai X, Huang CK. EMBO Mol Med. 2025 May;17(5):1101-1117. doi: 10.1038/s44321-025-00224-4. Epub 2025 Mar 31. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.